Trial Profile
A Multi-Center, Randomized, Blinded, Active [zolpidem; Ambien CR] and Placebo-Controlled, Crossover Study of the Efficacy and Safety of Two Doses of Adipiplon Bilayer Tablets in Primary Insomniacs
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Jun 2008
Price :
$35
*
At a glance
- Drugs Adipiplon (Primary) ; Zolpidem
- Indications Insomnia
- Focus Therapeutic Use
- Sponsors Neurogen Corporation
- 16 Jun 2008 New trial record.